Skip to main content
. 2022 Aug 22:1–12. Online ahead of print. doi: 10.1007/s10238-022-00871-8

Table 3.

Comparison between group in clinimetric indices at T0 and T1

Control group Treatment group All patients p-value
VAS fatigue
T0 6.0±1.8 (0–10) 6.3±2.5 (0–10) 6.2±2.3 (0–10) 0.413
T1 4.3±1.9 (0–8) 2.8±1.9 (0–8) 3.3±2.0 (0–8) <0.0001
VAS pain
T0 4.8±1.8 (0–8) 4.7±2.6 (0–9) 4.7±2.4 (0–9) 0.911
T1 4.0±1.6 (0–7) 1.9±1.7 (0–8) 2.6±1.9 (0–8) <0.0001
VAS sleep
T0 5.8±2.8 (0–10) 6.2±2.7 (0–10) 6.1±2.7 (0–10) 0.318
T1 4.4±2.4 (0–8) 2.6±2.0 (0–7) 3.2±2.3 (0–8) <0.0001
FSS
T0 27.1±8.6 (12–46) 32.4±17.0 (7–63) 30.6±14.9 (7–63) 0.608
T1 19.7±7.6 (7–40) 15.2±8.6 (2–40) 16.7±8.5 (2–40) <0.0001
WPI
T0 4.3±3.6 (1–19) 4.3±3.6 (0–19) 4.3±3.6 (0–19) 0.941
T1 3.3±3.1 (0–15) 1.4±2.1 (0–10) 2.0±2.6 (0–15) <0.0001
FAS
T0 15.4±8.2 (0–35) 16.8±7.1(0–36) 16.3±7.5 (0–36) 0.259
T1 12.0±6.9 (0–29) 6.8±4.5 (0–20) 8.6±6.0 (0–29) <0.0001
SSS
T0 5.9±2.8 (0–11) 6.1±2.9 (0–12) 6.0±2.9 (0–12) 0.589
T1 4.0±2.1 (0–7) 2.0±1.6 (0–6) 2.7±2.0 (0–7) <0.0001